NACDS Applauds Rejection of California State Legislation That Would Disempower Patients, Drive Up Healthcare Costs

Published Online: Friday, January 13, 2012
Follow Pharmacy_Times:
The National Association of Chain Drug Stores (NACDS) applauded the rejection of California legislation that would require a prescription for over-the-counter products containing pseudoephedrine, a key ingredient in cold and allergy medications.
 
This anti-consumer legislation (SB 315) would have mandated prescriptions for pseudoephedrine-containing products, thereby skyrocketing healthcare costs and reducing Californians’ access to health care, while not reducing the drug abuse and misuse of these products

NACDS joined state partners in California to oppose this legislation.  The Association testified before state lawmakers, highlighting community pharmacy’s commitment to working with law enforcement to help provide them access to the information they need to identify and stop this criminal activity, while ensuring patients have access to the over-the-counter medications that they rely on to treat illnesses.
 
NACDS also stressed that the prescription requirement would result in increased healthcare costs, resulting from an increase in doctors’ visits, prescription pharmacy costs, Medi-Cal costs and insurance premiums.
 
“We are pleased that California lawmakers rejected this anti-consumer legislation.  Requiring a prescription for over-the-counter products containing pseudoephedrine would be a cure worse than the disease,” said NACDS President and CEO Steven C. Anderson, IOM, CAE.  “A prescription requirement would disempower patients in their own healthcare and would only increase healthcare costs."

NACDS continues working with state and federal officials to curb pseudoephedrine misuse and abuse, emphasizing that a prescription-only approach would have detrimental impacts on patients and the healthcare system.
Related Articles
Pharmacists are getting closer to obtaining provider status, as federal legislation that would enable pharmacists to provide health care services to Medicare patients in underserved communities was today reintroduced in the US House of Representatives.
Bipartisan legislation introduced in the U.S. House of Representatives today would formally designate pharmacists as healthcare providers under Medicare Part B. Supported by the National Association of Chain Drug Stores, the bill would amend The Social Security Act of 1935 to enable pharmacists to provide to Medicare patients in underserved communities services that pharmacists already are providing for other patients under state law.
Emphasizing the importance of promoting policies that improve patient outcomes and lead to healthier, safer communities, the National Association of Chain Drug Stores submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health in lead-up to today’s hearing titled “Examining Public Health Legislation to Help Patients and Local Communities.”
In support of pharmacy refill reminder programs and other healthcare communications by pharmacies, the National Association of Chain Drug Stores recently filed comments with the Federal Communications Commission requesting regulatory clarification regarding prior consent for calls to consumers’ cell phones for healthcare notifications.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$